Clinical Trial Update: A Platform Trial for Personalized and Adaptive Therapies in Hepatocellular Carcinoma [Phase 2]

View source ↗

Summary

This is a Phase 2 platform trial in hepatocellular carcinoma exploring personalized and adaptive therapies. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Fudan University | Conditions: Hepato Cellular Carcinoma (HCC) | Phase 2 | Status: RECRUITING